文献速递神经技术与安全MRCT

影像组学可鉴别高级别胶质瘤与脑转移瘤:系统评价与Meta分析

Radiomics can differentiate high-grade glioma from brain metastasis: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2022-05-19

该系统评价与Meta分析纳入17项研究共1717例患者,评估影像组学鉴别高级别胶质瘤与脑转移瘤的诊断性能及方法学质量。10项无数据泄漏疑虑的研究定量合并后,汇总敏感度和特异度均为84%(95%CI分别为80-88%和81-87%)。平均RQS为5.13(占总分14.25%),作者建议未来研究采用标准化工作流程以避免潜在数据泄漏,并整合临床特征与影像组学。

要点

  • 影像组学鉴别高级别胶质瘤与脑转移瘤的汇总敏感度和特异度均为84%。
  • 基于VOI或(半)自动分割的特征提取模型性能优于ROI或手动分割方案。
  • 仅1项研究报道将临床特征纳入影像组学模型,仅1项研究公开算法代码。

核心结论

  • 影像组学能准确鉴别高级别胶质瘤与脑转移瘤,未来研究建议考虑采用标准化工作流程以避免潜在数据泄漏,并整合临床特征与影像组学。

研究设计与样本

  • 系统评价与Meta分析,检索截至2021年7月26日发表的影像组学研究,系统评价纳入17项研究共1717例患者,定量统计分析纳入10项无数据泄漏疑虑的研究,采用RQS系统评估方法学质量、QUADAS-2工具评估偏倚风险。

诊断标准与关键数值

  • 影像组学模型鉴别高级别胶质瘤与脑转移瘤的汇总敏感度为84%(95%CI 80-88%),汇总特异度为84%(95%CI 81-87%);平均RQS为5.13(占总分14.25%)。

临床应用与阅片要点

  • 特征提取从VOI或(半)自动分割入手的影像组学模型性能优于采用ROI或手动分割的方案;仅1项研究报道将临床特征纳入影像组学模型,仅1项研究公开算法代码。

局限性

  • 平均RQS为5.13(占总分14.25%),方法学质量有待提高。
  • 仅1项研究报道将临床特征纳入影像组学模型,仅1项研究公开算法代码。
  • 影像组学联合临床特征鉴别高级别胶质瘤与脑转移瘤的应用需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: (1) To evaluate the diagnostic performance of radiomics in differentiating high-grade glioma from brain metastasis and how to improve the model. (2) To assess the methodological quality of radiomics studies and explore ways of embracing the clinical application of radiomics.

METHODS: Studies using radiomics to differentiate high-grade glioma from brain metastasis published by 26 July 2021 were systematically reviewed. Methodological quality and risk of bias were assessed using the Radiomics Quality Score (RQS) system and Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool, respectively. Pooled sensitivity and specificity of the radiomics model were also calculated.

RESULTS: Seventeen studies combining 1,717 patients were included in the systematic review, of which 10 studies without data leakage suspicion were employed for the quantitative statistical analysis. The average RQS was 5.13 (14.25% of total), with substantial or almost perfect inter-rater agreements. The inclusion of clinical features in the radiomics model was only reported in one study, as was the case for publicly available algorithm code. The pooled sensitivity and specificity were 84% (95% CI, 80-88%) and 84% (95% CI, 81-87%), respectively. The performances of feature extraction from the volume of interest (VOI) or (semi) automatic segmentation in the radiomics models were superior to those of protocols employing region of interest (ROI) or manual segmentation.

CONCLUSION: Radiomics can accurately differentiate high-grade glioma from brain metastasis. The adoption of standardized workflow to avoid potential data leakage as well as the integration of clinical features and radiomics are advised to consider in future studies.

KEY POINTS: • The pooled sensitivity and specificity of radiomics for differentiating high-grade gliomas from brain metastasis were 84% and 84%, respectively. • Avoiding potential data leakage by adopting an intensive and standardized workflow is essential to improve the quality and generalizability of the radiomics model. • The application of radiomics in combination with clinical features in differentiating high-grade gliomas from brain metastasis needs further validation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Liu, Liang, et al. Radiomics can differentiate high-grade glioma from brain metastasis: a systematic review and meta-analysis. Eur Radiol. 2022. PMID: 35587827. doi:10.1007/s00330-022-08828-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。